Comparative analysis of the cost-effectiveness of teriparatide [RHPTH(1-34)] versus RHPTH(1-84)

被引:0
|
作者
Borgstroem, F. [1 ]
Stroem, O. [2 ]
Kutahov, A. [3 ]
Marin, F. [3 ]
Ljunggren, O. [4 ]
机构
[1] European Hlth Econ, Stockholm, Sweden
[2] Stockholm Hlth Econ, Stockholm, Sweden
[3] Eli Lilly Res Ctr Ltd, Windlesham, Surrey, England
[4] Univ Uppsala Hosp, Uppsala, Sweden
关键词
D O I
10.1016/S1098-3015(10)65387-9
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A396 / A396
页数:1
相关论文
共 50 条
  • [1] Continuous Subcutaneous Delivery of rhPTH(1-84) and rhPTH(1-34) by Pump in Adults With Hypoparathyroidism
    Charoenngam, Nipith
    Bove-Fenderson, Erin
    Wong, Daniel
    Cusano, Natalie E.
    Mannstadt, Michael
    [J]. JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 8 (05)
  • [2] Teriparatide (rhPTH(1-34) improves the structural geometry of the hip
    Uusi-Rasi, K
    Beck, TJ
    Oreskovic, TL
    Sato, M
    Boado, CE
    Zanchetta, JR
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S208 - S208
  • [3] Bisphosphonates affect signaling pathways utilized by teriparatide [rhPTH(1-34)].
    Sun, Q
    Katz, RW
    Morris, SA
    Bilezikian, JP
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S230 - S231
  • [4] Pharmacokinetics of Teriparatide (rhPTH[1-34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis
    Satterwhite, Julie
    Heathman, Michael
    Miller, Paul D.
    Marin, Fernando
    Glass, Emmett V.
    Dobnig, Harald
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2010, 87 (06) : 485 - 492
  • [5] Teriparatide [RHPTH (1-34)] treatment reduces the incidence of back pain in postmenopausal women with osteoporosis
    Krege, JH
    Xie, L
    Genant, HK
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S75 - S75
  • [6] Effects of Intravenous Zoledronic Acid Plus Subcutaneous Teriparatide [rhPTH(1-34)] in Postmenopausal Osteoporosis
    Cosman, Felicia
    Eriksen, Erik Fink
    Recknor, Chris
    Miller, Paul D.
    Guanabens, Nuria
    Kasperk, Christian
    Papanastasiou, Philemon
    Readie, Aimee
    Rao, Hanumantha
    Gasser, Juerg A.
    Bucci-Rechtweg, Christina
    Boonen, Steven
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (03) : 503 - 511
  • [7] Teriparatide (rhPTH [1-34]) treatment improves the structure of the proximal femur in women with osteoporosis.
    Semanick, LM
    Uusi-Rasi, K
    Zanchetta, JR
    Bogado, CE
    Eriksen, EF
    Sato, M
    Beck, TJ
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S40 - S40
  • [8] Raloxifene improves the skeletal efficacy of teriparatide [RHPTH (1-34), TPTD] at clinically relevant doses
    Sato, M
    Schmidt, A
    Smith, S
    Ma, LY
    [J]. BONE, 2003, 32 (05) : S211 - S212
  • [9] RALOXIFENE SKELETAL EFFECTS ARE IMPROVED WITH WEEKLY TERIPARATIDE [RHPTH (1-34)] IN OSTEOPENIC OVARIACTOMIZED RATS
    Ma, Y. L.
    Schmidt, A.
    Zeng, Q. Q.
    Zhang, Q.
    Jee, W. S.
    Sato, M.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S83 - S83
  • [10] Continuous rhPTH (1-34) treatment in chronic hypoparathyroidism
    Fuss, Carmina Teresa
    Burger-Stritt, Stephanie
    Horn, Silke
    Koschker, Ann-Cathrin
    Frey, Kathrin
    Meyer, Almuth
    Hahner, Stefanie
    [J]. ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2020, : 1 - 6